Drug Shortage Report for ACT ESCITALOPRAM ODT

Last updated on 2023-06-09 History
Report ID 169995
Drug Identification Number 02454300
Brand name ACT ESCITALOPRAM ODT
Common or Proper name ACT ESCITALOPRAM
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ESCITALOPRAM
Strength(s) 20MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 30
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-22
Estimated end date 2023-05-20
Actual end date 2023-06-08
Shortage status Resolved
Updated date 2023-06-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2023-06-09 English Compare
v15 2023-06-08 French Compare
v14 2023-06-08 English Compare
v13 2023-04-27 French Compare
v12 2023-04-27 English Compare
v11 2023-02-13 French Compare
v10 2023-02-13 English Compare
v9 2023-02-02 French Compare
v8 2023-02-02 English Compare
v7 2023-01-12 French Compare
v6 2023-01-12 English Compare
v5 2022-12-01 French Compare
v4 2022-12-01 English Compare
v3 2022-09-23 English Compare
v2 2022-09-22 French Compare
v1 2022-09-22 English Compare

Showing 1 to 16 of 16